ARDTArdent Health Inc.Healthcare · Medical - Care Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $10.72 · now $10.72 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ARDT has typically landed between $8.75 and $12.67 — a range of −18.4% to +18.2% from the issuance price $10.72.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

522 overlapping 1 month windows · 2024-07-182026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($10.72) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ARDT has typically landed a month from the 2026-09-16 close of $10.72 — the range is history, not a prediction.

$8.75worst · -18.4%$12.67best · +18.2%
  • now $10.72 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $10.74 (+0.2%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $9.88$11.59
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $8.75$12.67
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 522 windows spanning 2024-07-18 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-10-17−43.4%−43.4%+4.0%
2025-10-21−42.4%−44.7%+1.6%
2025-10-22−41.8%−44.2%+2.5%
3 best
2026-06-03+38.2%+0.0%+38.2%
2025-04-21+30.7%+0.0%+33.1%
2025-04-22+26.5%+0.0%+30.5%

522 overlapping windows · 2024-07-182026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~3 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
0%
−9.8%
n=2
Feb
50%
+6.3%
n=2
Mar
0%
−7.5%
n=2
Apr
50%
+3.3%
n=2
May
50%
+4.2%
n=2
Jun
50%
+0.5%
n=2
Jul
50%
−7.0%
n=2
Aug
100%
+10.7%
n=3
Sep
33%
−1.3%
n=3
Oct
50%
+2.3%
n=2
Nov
0%
−23.9%
n=2
Dec
100%
+3.7%
n=2

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$15$82026-06-05: 2 insider purchases, $186K — DeMichiei Robert, LUMSDAINE ALFRED2026-06: 2 open-market purchases, $186K↑ buys↓ salesdirector DeMichiei Robert — Purchase on 2026-06-05, filed 3 days after the tradeofficer LUMSDAINE ALFRED — Purchase on 2026-06-05, filed 3 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-06-05DeMichiei RobertdirectorPurchase11,260 @ $8.73$98K+46.3% of holding+15.6%not yet — horizon still open35,564Form 4 · filed 3 days after the trade
2026-06-05LUMSDAINE ALFREDofficerPurchase10,000 @ $8.81$88K+3.1% of holding+15.6%not yet — horizon still open329,183Form 4 · filed 3 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

63 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-07-01Caspers DavedirectorAward / grant103,653174,930Form 4
2026-04-01Bonick MartindirectorWithheld for tax10,9521,303,322Form 4
2026-04-01LUMSDAINE ALFREDofficerWithheld for tax4,381265,337Form 4
2026-04-01Caspers DavedirectorWithheld for tax2,68435,604Form 4
2026-04-01Petrovich Stephen C.officerWithheld for tax1,808749,803Form 4
2026-04-01Byers David RaynorofficerWithheld for tax924118,907Form 4
2026-04-01Bonick MartindirectorAward / grant134,6151,437,937Form 4
2026-04-01Havdala EllendirectorAward / grant14,231115,367Form 4
2026-04-01DeMichiei RobertdirectorAward / grant14,23124,304Form 4
2026-04-01LUMSDAINE ALFREDofficerAward / grant53,846319,183Form 4
2026-04-01Sotir Mark RdirectorAward / grant14,23138,709Form 4
2026-04-01Byers David RaynorofficerAward / grant11,538130,445Form 4
2026-04-01Sen RahuldirectorAward / grant14,23138,709Form 4
2026-04-01Webb Robert ThomasdirectorAward / grant14,23178,215Form 4
2026-04-01Petrovich Stephen C.officerAward / grant24,904774,707Form 4
2026-04-01Bulgarelli Peter J.directorAward / grant14,23114,231Form 4
2026-04-01Caspers DavedirectorAward / grant35,67371,277Form 4
2026-04-01BYNOE PETER C BdirectorAward / grant14,231115,367Form 4
2026-04-01Campion SuzannedirectorAward / grant14,23158,215Form 4
2026-04-01Robinson EdmondodirectorAward / grant14,23158,215Form 4
2026-04-01GOODYEAR WILLIAM MdirectorAward / grant14,231115,367Form 4
2026-03-31Bonick MartindirectorWithheld for tax8,0261,314,274Form 4
2026-03-31LUMSDAINE ALFREDofficerWithheld for tax2,510269,718Form 4
2026-03-31Petrovich Stephen C.officerWithheld for tax1,425751,611Form 4
2026-03-31Byers David RaynorofficerWithheld for tax819119,831Form 4
2026-03-11LUMSDAINE ALFREDofficerAward / grant61,081272,228Form 4
2026-03-11Bonick MartindirectorAward / grant195,3161,322,300Form 4
2026-03-11Petrovich Stephen C.officerAward / grant34,733753,036Form 4
2026-03-11Byers David RaynorofficerAward / grant8,859120,650Form 4
2026-03-11Chernin EthanofficerAward / grant32,40868,396Form 4
2025-09-25LUMSDAINE ALFREDofficerWithheld for tax3,389211,147Form 4
2025-09-25Petrovich Stephen C.officerWithheld for tax788718,303Form 4
2025-09-25Byers David RaynorofficerWithheld for tax524111,791Form 4
2025-04-02DeMichiei RobertdirectorAward / grant10,07310,073Form 4
2025-04-01Caspers DavedirectorWithheld for tax2,4805,231Form 4
2025-04-01Caspers DavedirectorAward / grant33,05738,288Form 4
2025-04-01Chernin EthanofficerAward / grant20,91435,988Form 4
2025-04-01LUMSDAINE ALFREDofficerAward / grant53,971214,536Form 4
2025-04-01Bonick MartindirectorAward / grant134,9271,126,984Form 4
2025-04-01Petrovich Stephen C.officerAward / grant22,263719,091Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.